Ann: Ceasing to be a substantial holder, page-5

Bionomics Limited (ASX:BNO) Under Investor Scrutiny as Price Index Touches 1.41892 Investors are keeping a close eye on shares of Bionomics Limited (ASX:BNO). The stock has a current six month price index of 1.41892. The six month price index is calculated by dividing the current share price by the share price six months ago. A ratio over one represents an increase in the stock price over the six month time frame. A ratio under one shows that the price has lowered over that defined time period. For any technician, the trend is a major aspect of stock trading. The trend is the dominant movement in direction of a stock’s price. When discussing the trend in terms of stock price, the assumption is that the trend is expected to continue over a certain period of time. Obviously there is no guarantee that a defined trend will continue, but technical analysts will scour the charts looking for signs of a developed trend to help make the best possible decisions. Seasoned chart watchers are typically able to spot if a trend is up, down, or sideways. Learning how to trade the trend is another part of the process that traders may spend years perfecting. We can also take a look at some stock volatility data on shares of Bionomics Limited (ASX:BNO). The 12 month volatility is currently 46.388300. The 6 month volatility is noted at 54.038600, and the 3 month is recorded at 48.284800. When following the volatility of a stock, investors may be challenged with trying to decipher the correct combination of risk-reward to help maximize returns. As with any strategy, it is important to carefully consider risk and other market factors that might be in play when examining stock volatility levels. Investors may be looking at the Piotroski F-Score when doing value analysis. The F-Score was developed to help find company stocks that have solid fundamentals, and to separate out weaker companies. Piotroski’s F-Score uses nine tests based on company financial statements. Bionomics Limited (ASX:BNO) currently has a Piotroski F-Score of 3. One point is given for piece of criteria that is met. Typically, a stock with a high score of 8 or 9 would be seen as strong, and a stock scoring on the lower end between 0 and 2 would be viewed as weaker. Traders may be going deeper into the playbook in order to scoop up profits in the current stock market environment. The first half of the year has produced plenty of big winners. Investors will be closely monitoring the most recent earnings releases to hopefully spot the next big mover. Traders may be looking to more closely define some major trends in order to identify which way the momentum is going to carry the stock market into the close of the calendar year. Keeping track of all the financial news and global happenings can be a tall order, even for the most seasoned investors. Staying the course while following a sound investing plan can help the individual investor become prepared for whatever lies ahead. The optimists still believe there is much more room for growth in the markets while the pessimists are calling for a major reversal in the near future. Traders and investors will be closely tracking the major economic news to help come to a solid conclusion about which way the markets are headed. Staying up on the fundamentals as well as the popular technical indicators may help the investor sort through the maze and prepare for the next stage. The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of Bionomics Limited (ASX:BNO) is -0.027226. Ever wonder how investors predict positive share price momentum? The Cross SMA 50/200, also known as the “Golden Cross” is the fifty day moving average divided by the two hundred day moving average. The SMA 50/200 for Bionomics Limited (ASX:BNO) is currently 1.21781. If the Golden Cross is greater than 1, then the 50 day moving average is above the 200 day moving average – indicating a positive share price momentum. If the Golden Cross is less than 1, then the 50 day moving average is below the 200 day moving average, indicating that the price might drop. The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Bionomics Limited (ASX:BNO) is 2.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books. For the average investor, figuring out how to best approach the stock market can be challenging. Many investors have probably seen at least one of their prized stocks take off in the last year, and they may be wondering which one is next. With the stock market still trading at super high levels, investors may be worried that a major shift will occur in the near future. Looking back over the first part of this year, investors may not have too much to fidget within the portfolio. If the stock market decides to reverse course and take a turn for the worse, investors may start questioning their strategy and become somewhat worried. Drastic shifts in the markets happen from time to time. Investors who are prepared for volatile market environments may be much better suited to weather the storm than those who are not. Crafting a plan that accounts for the regular ups and downs of the market may be a wise choice for the individual investor. This may mean shifting the mindset to be on the lookout for opportunities when they become available. Investors who have done the research and planning might be more secure in their stock choices should turbulent times arise